Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation

OBJECTIVES: Compare the effect of apixaban and warfarin on coagulation and primary haemostasis biomarkers in atrial fibrillation (AF). METHODS: The biomarker substudy from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial included 4850 patients with AF...

Descripción completa

Detalles Bibliográficos
Autores principales: Christersson, Christina, Wallentin, Lars, Andersson, Ulrika, Alexander, John H, Alings, Marco, De Caterina, Raffaele, Gersh, Bernard J, Granger, Christopher B, Halvorsen, Sigrun, Hanna, Michael, Huber, Kurt, Hylek, Elaine M, Lopes, Renato D, Oh, Byung-Hee, Siegbahn, Agneta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Arrhythmias and Sudden Death
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388910/
https://www.ncbi.nlm.nih.gov/pubmed/30209126
http://dx.doi.org/10.1136/heartjnl-2018-313351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388910/
https://www.ncbi.nlm.nih.gov/pubmed/30209126
http://dx.doi.org/10.1136/heartjnl-2018-313351

Ejemplares similares